Reply

Ananth Thyagarajan; Pooja Varshney; Stacie M. Jones; Scott Sicherer; Robert Wood; Brian P. Vickery; Hugh Sampson; A. Wesley Burks

doi:10.1016/j.jaci.2010.08.051

Reply

Ananth Thyagarajan, Pooja Varshney, Stacie M. Jones, Scott Sicherer, Robert Wood, Brian P. Vickery, Hugh Sampson, A. Wesley Burks

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	291-292
Number of pages	2
Journal	Journal of Allergy and Clinical Immunology
Volume	127
Issue number	1
DOIs	https://doi.org/10.1016/j.jaci.2010.08.051
State	Published - Jan 2011

Access to Document

10.1016/j.jaci.2010.08.051

Cite this

@article{2244b2945984414fac961f186a878ced,

title = "Reply",

author = "Ananth Thyagarajan and Pooja Varshney and Jones, {Stacie M.} and Scott Sicherer and Robert Wood and Vickery, {Brian P.} and Hugh Sampson and Burks, {A. Wesley}",

note = "Funding Information: Disclosure of potential conflict of interest: S. M. Jones has received research support from the National Peanut Board , the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID), and DYAX Corp ; is on the Medical Advisory Board for the Food Allergy & Anaphylaxis Network; and is a Steering Committee Member for Sanofi-Aventis. S. Sicherer is a consultant for the Food Allergy Initiative, is an advisor for the Food Allergy & Anaphylaxis Network, and has received research support from the NIH/NIAID and the Food Allergy Initiative . B. P. Vickery has received research support from the Thrasher Research Fund, the NIH/NIAID, and the American Lung Association . H. Sampson is a consultant for Allertein; has received research support from the Food Allergy Initiative and NIH/NIAID ; is a consultant/scientific advisor for the Food Allergy Initiative; and is 45% owner of Herbal Springs, LLC. A. W. Burks is a consultant for ActoGeniX NV, Intelliject, McNeil Nutritionals, Novartis, and Schering-Plough; is a minority stockholder for Allertein and MastCell, Inc; is on the advisory board for Dannon Co Probiotics; is on the expert panel of Nutricia; has received research support from the NIH, Food Allergy & Anaphylaxis Network, and Wallace Research Foundation ; has served as an expert witness on the topic of food allergy; is on the Medical Board of Directors for the Food Allergy & Anaphylaxis Network; is a Dermatological Allergy Committee Member of the American College of Allergy, Asthma & Immunology; is a Study Section Member of the NIH/Hypersensitivity, Autoimmune and Immune-mediated Diseases; and is on the reviewer board for the Journal of Allergy and Clinical Immunology and the US Food and Drug Administration. The rest of the authors have declared that they have no conflict of interest. ",

year = "2011",

month = jan,

doi = "10.1016/j.jaci.2010.08.051",

language = "English",

volume = "127",

pages = "291--292",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Reply

AU - Thyagarajan, Ananth

AU - Varshney, Pooja

AU - Jones, Stacie M.

AU - Sicherer, Scott

AU - Wood, Robert

AU - Vickery, Brian P.

AU - Sampson, Hugh

AU - Burks, A. Wesley

N1 - Funding Information: Disclosure of potential conflict of interest: S. M. Jones has received research support from the National Peanut Board , the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID), and DYAX Corp ; is on the Medical Advisory Board for the Food Allergy & Anaphylaxis Network; and is a Steering Committee Member for Sanofi-Aventis. S. Sicherer is a consultant for the Food Allergy Initiative, is an advisor for the Food Allergy & Anaphylaxis Network, and has received research support from the NIH/NIAID and the Food Allergy Initiative . B. P. Vickery has received research support from the Thrasher Research Fund, the NIH/NIAID, and the American Lung Association . H. Sampson is a consultant for Allertein; has received research support from the Food Allergy Initiative and NIH/NIAID ; is a consultant/scientific advisor for the Food Allergy Initiative; and is 45% owner of Herbal Springs, LLC. A. W. Burks is a consultant for ActoGeniX NV, Intelliject, McNeil Nutritionals, Novartis, and Schering-Plough; is a minority stockholder for Allertein and MastCell, Inc; is on the advisory board for Dannon Co Probiotics; is on the expert panel of Nutricia; has received research support from the NIH, Food Allergy & Anaphylaxis Network, and Wallace Research Foundation ; has served as an expert witness on the topic of food allergy; is on the Medical Board of Directors for the Food Allergy & Anaphylaxis Network; is a Dermatological Allergy Committee Member of the American College of Allergy, Asthma & Immunology; is a Study Section Member of the NIH/Hypersensitivity, Autoimmune and Immune-mediated Diseases; and is on the reviewer board for the Journal of Allergy and Clinical Immunology and the US Food and Drug Administration. The rest of the authors have declared that they have no conflict of interest.

PY - 2011/1

Y1 - 2011/1

UR - http://www.scopus.com/inward/record.url?scp=78650893143&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2010.08.051

DO - 10.1016/j.jaci.2010.08.051

M3 - Letter

AN - SCOPUS:78650893143

SN - 0091-6749

VL - 127

SP - 291

EP - 292

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 1

ER -